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Abstract
Background: The phenotypic effects of sequence variations in protein-coding regions come about
primarily via their effects on the resulting structures, for example by disrupting active sites or affecting
structural stability. In order better to understand the mechanisms behind known mutant phenotypes, and
predict the effects of novel variations, biologists need tools to gauge the impacts of DNA mutations in terms
of their structural manifestation. Although many mutations occur within domains whose structure has been
solved, many more occur within genes whose protein products have not been structurally characterized.
Results: Here we present 3DSim (3D Structural Implication of Mutations), a database and web application
facilitating the localization and visualization of single amino acid polymorphisms (SAAPs) mapped to protein
structures even where the structure of the protein of interest is unknown. The server displays information
on 6514 point mutations, 4865 of them known to be associated with disease. These polymorphisms are
drawn from SAAPdb, which aggregates data from various sources including dbSNP and several pathogenic
mutation databases. While the SAAPdb interface displays mutations on known structures, 3DSim projects
mutations onto known sequence domains in Gene3D. This resource contains sequences annotated with
domains predicted to belong to structural families in the CATH database. Mappings between domain
sequences in Gene3D and known structures in CATH are obtained using a MUSCLE alignment. 1210 three-
dimensional structures corresponding to CATH structural domains are currently included in 3DSim; these
domains are distributed across 396 CATH superfamilies, and provide a comprehensive overview of the
distribution of mutations in structural space.
Conclusion: The server is publicly available at http://3DSim.bioinfo.cnio.es/. In addition, the database
containing the mapping between SAAPdb, Gene3D and CATH is available on request and most of the
functionality is available through programmatic web service access.
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The most common biologically-relevant mutations are
single base changes often referred to as single nucleotide
polymorphisms (SNPs). These account for about 90% of
sequence polymorphisms in humans [1] at an overall fre-
quency of about one per 1000 bases [2]. Traditionally,
SNPs are classified as coding or non-coding according to
their genomic location – coding SNPs are further sub-clas-
sified according to the protein product expressed. Non-
Synonymous SNPs (nsSNPs) are those that alter the
amino acid sequence of the protein product, either
through amino acid substitution (a 'single amino acid
polymorphisms', SAAP), or by the generation of trunca-
tion mutations. By contrast, synonymous SNPs (also
referred to as silent or sSNPs) are those that do not alter
the amino acid sequence of the protein product.
Not all synonymous SNPs are neutral since they may still
affect the expression of gene products or protein transla-
tion by introducing alterations into regulatory regions,
interfering with splice sites or impinging on other regula-
tory mechanisms [3,4]. Similarly, not all nsSNPs are asso-
ciated with pathological diseases, since some changes are,
by nature, milder than others, and diseases commonly
involve complex sets of alterations.
Strictly the term 'SNP' is defined as a mutation which
occurs in at least 1% of a 'normal' population. Thus SNPs
are expected to have a neutral non-deleterious or low-pen-
etrance phenotypic effect whereas the term pathogenic
deviation (PD) refers to those mutations that generally
occur at much lower frequencies in the population and
have a severe effect on phenotype.
The most commonly used database for storing informa-
tion on SNPs is dbSNP [5], which currently contains sev-
eral million validated SNPs from humans and other
species. Other sources of genomic information about
SNPs include Ensembl [6] and the HapMap Project [7].
Several efforts have been devoted to the prediction of the
pathogenicity of amino acid mutations, resulting from
single nucleotide changes. These methods make use of a
set of characteristics which may be based both on
sequence and structure, to determine whether a mutation
can affect protein function and therefore be, potentially,
associated with disease. This is an area of active research
as shown by the considerable number of publications on
the subject during the last few years [8-18].
Several efforts, SAAPdb [19] among others, have been
devoted to compiling this information and to providing a
sequence and structural analysis, where possible, aiming
to determine the origin of the pathogenicity shown. In
this type of repository, the term SNP is used to refer to
essentially phenotypically silent mutations, while PD is
used for mutations known to have a severe effect on phe-
notype, i.e. any single base change reported to correlate
with disease. Online Mendelian Inheritance in Man
(OMIM) [20] is a collection of information about inher-
ited disease and contains data on PDs. However a great
deal more information is held and maintained by individ-
ual research groups in locus-specific mutation databases
or LSMDBs [21]. Like PDs, nsSNPs are point mutations,
but by definition they occur in at least 1% of a 'normal'
population. They are expected to have a neutral non-dele-
terious or low-pentrance phenotypic effect whereas PDs
are known to be detrimental. By mapping these SAAPs (a
term we use for both PDs and mutations resulting from
nsSNPs) onto protein structures, we can begin to under-
stand how protein structure might be affected by mutant
residues, and so begin to explain the functional effect (if
any) of the mutation. SAAPdb provides potential explana-
tions for both PDs, derived from various sources, and
SNPs, derived from dbSNP [5].
The CATH [22] structural domain database is a manually
curated classification of domain structures found in the
Protein Data Bank (PDB) [23], grouped according to evo-
lutionary relationships and structural features. Hidden
Markov Models (HMMs) are derived from alignments of
these structural exemplars and used by Gene3D [24] to
identify homologues within the protein sequences of Uni-
Prot [25], RefSeq [20] and Ensembl [6].
Here we present 3DSim (3D Structural Implication of
Mutations), a system mapping single amino-acid poly-
morphisms onto structures of CATH domains. For
sequences with no known structure, the Gene3D resource
of domain structure annotations is used to map the
sequence onto the closest homologous domain of known
structure in CATH. Thus 3DSim is of particular interest
when no structural information is available for a protein
in which mutations are known to occur as it uses sequence
homology to map to the closest representative structure.
This provides a comprehensive overview of the distribu-
tion of mutations in structural space, as well as a visuali-
zation tool for pinpointing the locations of mutations on
individual structures rendered in Jmol http://
www.jmol.org/, as well as links to detailed information
on each sequence, structure and mutation. The 3DSim
application, which was designed with the aim of being
very intuitive, easy to use and user-friendly, is publicly
available at http://3DSim.bioinfo.cnio.es/. Several
worked examples are available, along with a 6-minute
video tutorial. In addition, for those advanced users need-
ing intensive programmatic access to the information
stored, the underlying database containing the mappings
between SAAPdb, Gene3D and CATH is available onPage 2 of 8
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services implemented in SOAP.
Results and discussion
The mapping between SAAPdb and Gene3D
SAAPdb contains polymorphism data for 11956
sequences without a structure. Almost all of these could be
mapped to Gene3D: 11904 identical sequences were
found in the Gene3D database. Of the remaining 52, 17
had sequences with the same length and associated uni-
prot accession, leaving only 35 for which a reliable match
could not be obtained directly.
The mapping between Gene3D and CATH
Where no structural data are available, the best represent-
ative CATH domain is selected on the basis of homology.
For each of the 2179 superfamilies in CATH, a database of
all CATH domains was built. For each of the 11904
Gene3D domain sequences mapped to CATH structural
superfamilies for which there is information about muta-
tions in SAAPdb (see previous section), a BLAST [26]
search was run against the corresponding superfamily
database. The closest relative found (i.e. the one with the
lowest e-value and highest sequence identity) was used to
cluster the sequences. Sequences with a sequence identity
less than 20% were placed in separate clusters. This proc-
ess yielded 2091 different groups. The groups (including
the sequence of the representative structure) were then
aligned using MUSCLE [27] and the resulting alignments
used to transfer the mutations from Gene3D sequences to
CATH domain representative structures. At the end of the
pipeline we were able to display information on 6514
point mutations, 4865 of them known to be associated
with disease, mapping to 396 CATH superfamilies. The
complete pipeline is described in Figure 1 and details are
provided in the Methods section.
Description of web application
The initial input for the system is a CATH superfamily
identifier for which the user wants to retrieve information
on mapped mutations. Alternatively, the database can be
searched using Uniprot accession codes or CATH domain
identifiers. The user can either manually introduce the
desired superfamily identifier in the provided form, or
browse the superfamilies in CATH in order to access the
information. After this initial step, information about the
The mapping pipelineFigure 1
The mapping pipeline. Illustration of the mapping process between SAAPdb and CATH via Gene3DPage 3 of 8
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CATH domains for which there is information about
mutations in SAAPdb.
In addition, for users that are interested in a general over-
view of the distribution of mutations within structural
superfamilies in CATH, one can obtain a list of the super-
families with known mutations and analyze domains in
that superfamily.
Once the user has selected a CATH domain, 3DSim dis-
plays both an interactive Jmol plug-in that allows the vis-
ualization of the mutations projected onto the three-
dimensional structure of the representative CATH domain
and a table displaying all the information available for
that given domain in terms of available mutations,
sequence and structure positions of the mutations, patho-
genicity information, and similarity (BLAST sequence
identity) between the sequences in Gene3D and the repre-
sentative CATH domain sequence.
This similarity index provides the user with a hint about
the reliability of the homology based transference of
mutations between sequences in Gene3D and the struc-
tures in CATH. As a rule of thumb, the higher the similar-
ity the more reliable the transference of mutations is.
Tweaking this index is of particular interest when there are
few mutations in the close relatives for a given structural
family and looser constrains need to be taken into
account to allow more mutations in the analysis. By
default, the server rejects those mutations transferred from
sequences obtaining a BLAST sequence identity of less
than 20%, but – due to the interactive approach of the
server – the user can decide to establish more stringent
constrains depending on the study case.
In addition, the site is linked to several external annota-
tion providers (including CATH, Gene3D, SAAPdb, Mod-
base, PDBsum and UniProt) where more information
about the mutations, the proteins and the structures can
be gathered. In particular, SAAPdb provides information
about the structural implications of mutations. This infor-
mation can be related, in some cases, to the pathogenic
character of the mutations and provides an insight into
the mechanism of molecular function for several proteins.
Figure 2 shows a worked example of the different views
available through the server's graphical user interface.
Description of web services
In order to allow remote programmatic access to the infor-
mation contained in the database, we have developed a
total of nine SOAP web services, powered by the Perl
SOAP::Lite toolkit http://www.soaplite.com/. These allow
users to retrieve in simple XML format:
• all known mutations for a given CATH domain,
grouped by UniProt ID.
• the total number of mutations in a CATH domain.
• all the CATH domains which are associated with a
given UniProt ID.
• the amino-acid sequence of a given CATH domain.
• all CATH domains in a CATH superfamily, queried
by the four-part CATH code.
• the superfamily to which a given CATH domain
belongs.
• the description and representative structure associ-
ated with a given CATH superfamily.
• all the mutations in SAAPdb for a given UniProt
accession.
• the total number of mutations in SAAPdb for a given
UniProt accession.
The web interfaceFigur  2
The web interface. A collage showing a worked example 
of the different sections available through the server's graphi-
cal user interface. a) Browsable list of superfamilies b) Exam-
ple of structure displaying known pathogenic mutations c) 
Explanatory table of the mutationsPage 4 of 8
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construction of computational analysis pipelines. For
example, a user starting with a UniProt protein of interest
could retrieve a list of all the domains found in that pro-
tein, then the CATH superfamilies to which each domain
belongs, then all the other domains found in each super-
family, and filly all known mutations in those related
domains, by chaining together four web service calls.
More information is provided at http://3DSim.bio
info.cnio.es/webservices.html. The page contains example
Perl code for querying the web-services, and examples of
output from each one.
Database update
The database storing the information presented by both
the webserver and the webservice intrinsically depends on
the other databases providing the source information (i.e.
CATH, Gene3D and SAAPdb), each one being updated at
its own pace. This fact, in addition to the computationally
expensive calculations needed to compute the mapping
between Gene3D and the representative structures in
CATH, makes it impossible to schedule an automatic
updating calendar. Therefore, the database will be
updated based on a release system, where new versions
will be made public as regularly as possible.
Typical usage example
As an illustrative example, here we present the case of the
ATP binding subunit of the kinases (CATH superfamily
1.10.510.10) which is accessible through the server's web
page http://3DSim.bioinfo.cnio.es. This superfamily cor-
responds to the Phosphotransferase domain I homology
group in CATH, and is subdivided into a number of differ-
ent domains. However, for this particular example, we
will focus only on the domain with the highest number of
mutations (24), 1rw8A02. Of these 24 mutations, only
three come from the sequence which maps directly to the
domain. The remaining 21 come from homologous
sequences with 40–65% sequence identity identified via
Gene3D (Table 1). Figure 3 shows the structure with the
pathogenic deviations coloured in blue. This image can be
obtained directly from the server, and is one of the main
features available for the analysis of the distribution of
mutations within structures. Additional links to other
structure-based databases such as PDBsum [28] are pro-
vided in order to enhance the information provided, for
this particular case, the position of the catalytic site,
involved in binding of ATP, is described to be near resi-
dues from 333 to 338. Visual inspection of the position of
the pathogenic deviations reveals that they tend to cluster
around this catalytic core of the structure. Indeed, the
higher the similarity in terms of BLAST identity between
the CATH domain and the Gene3D sequence, the closer
these positions are to the binding core and hence, more
reliable the observations are.
This PDB chain (1rw8A) maps to the UniProtKB/Swiss-
Prot accession P36897 and the information provided by
the UniProt record (accessible through the web server's
cross references) shows that it corresponds to the TGF-
beta receptor type-1 precursor in humans
(TGFR1_HUMAN) for which there is a level of association
with disease, in particular to Furlong syndrome also
known as Loeys-Dietz syndrome type 1A (LDS1); [29].
LDS1 is an aortic aneurysm syndrome with widespread
systemic involvement. The disorder is characterized by
arterial tortuosity and aneurysms, craniosynostosis,
hypertelorism, and bifid uvula (cleft palate). Other find-
ings include exotropy, micrognathia and retrognathia,
structural brain abnormalities, intellectual deficit, con-
genital heart disease, translucent skin, joint hyperlaxity
and aneurysm with dissection throughout the arterial tree.
The mutations listed as pathogenic deviations (R487P,
M318R and D400G) in the server for this protein, which
has a 100% identity between the Gene3D sequence and
the representative structure of the CATH domain are
reported in the literature [29] as involved in LDS1 devel-
opment.
Table 1: Mutations mapped to 1rw8A02. SwissProt accession P36897 maps directly to PDB code 1rw8 chain A and to CATH domain 
1rw8A02 which represents residues 285–500. Other SwissProt entries containing known pathogenic deviations (PDs) are mapped to 
this domain via Gene3D and the mutations are mapped to the 1rw8 structure.
SwissProt Accession Domain Range Sequence Identity Mutations
P36897 285–500 100% M318R, D400G, R487P
O00238 284–499 65% R486W
P36894 314–529 62% A338D, C376Y, M470T
P37023 282–497 60% C344Y, R374W, M376R
I398N, W399S, R411P
R411Q, R411W, R484W
P37173 330–546 40% Y336N, A355P, G357W
S449F, E526Q, R528C
R528H, R537CPage 5 of 8
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We have presented 3DSim (3D Structural Implication of
Mutations), a system that enables the localization and vis-
ualization of single amino acid polymorphisms projected
onto protein structures based on homologous relation-
ships captured in the CATH and Gene3D databases. This
provides a comprehensive overview of the distribution of
mutations in structural space.
Although there are other servers mapping mutations to
structure already (reviewed by Uzun et al. [30]) the server
presented here has several unique features not available in
existing servers. Firstly, the similar treatment of SNPs and
the rarer more harmful PDs allows users to inspect and
compare both kinds of mutation through the same inter-
face, including explanatory metadata where available. Sec-
ondly, the localization of these SAAPs within the CATH
hierarchy allows users to query and explore the distribu-
tion of mutations at various levels of structural classifica-
tion. Thirdly, the mapping of sequences onto
homologous CATH domains via Gene3D helps users pre-
dict the effects of polymorphisms in proteins whose struc-
ture has not been solved. Finally, the availability of the
data via web services and database dumps enables power
users to include this information efficiently in their own
analyses. These facilities allow the independent integra-
tion of our data in any other pipeline or workflow.
The server has been running internally since we started
working on the analysis of point mutations in protein
families [31,32] and is accessible at http://3DSim.bio
info.cnio.es/. Examples and documentation are also avail-
able, together with a tutorial video and samples of outputs
of the main functions. This website is available to all users
with no login requirement. It is likely that we will include
additional features related with the structural interpreta-
tion of mutations and their relationship with disease, after
receiving feedback from external users.
In summary the 3DSim server provides up-to-date, com-
plete information automatically to map mutations in the
domain sequences of proteins annotated in Gene3D onto
protein structures classified in the CATH database.
Methods
Obtaining the mutations from SAAPdb
SAAPdb [19] is a database of single amino acid polymor-
phisms (SAAPs) from several resources, such as dbSNP
[5], ADABase [33], G6PD [34] HAMSTeRs [35], IARC p53
Database [36], LDLR [37], OMIM http://
www.ncbi.nlm.nih.gov/omim/, OTC [38], SOD1db [39]
and ZAP70Base [33], mapped to protein structure, where
available in the PDB [23]. As of October 2008, SAAPdb
contains 9060 unique pathogenic deviations (PDs: SAAPs
associated to a disease) and 2532 unique single nucle-
otide polymorphisms (SNPs: SAAPs with no known path-
ogenic effect) successfully mapped to the UniProtKB [25]
sequences in Gene3D [24].
Both pathogenic deviations and single nucleotide poly-
morphisms were only taken into account if the alteration
introduced was non-silent, that is, if the mutation is both
in a coding residue and the resulting amino acid is differ-
ent from the native one. Where mutations are recorded
both as neutral and disease-associated, the mutations
were considered pathogenic.
Gene3D domain assignments
The process by which homologues of CATH domains are
identified in sequences, and presented in the Gene3D
database, has been described previously [40]. For this par-
ticular dataset, the CATH v3.2.0 Hmmer HMM library was
scanned against the UniProt (Swiss-Prot and TrEMBL)
sequence database in collaboration with the SIMAP data-
base [41]. FASTA files of each superfamily were generated
by extracting the subsequences of the domains belonging
to each superfamily.
Gathering the sequences from Gene3D
For each CATH superfamily a library of one or more
HMMs is generated using the SAM Target2K procedure
[22]. These HMMs are then searched against UniProt in
collaboration with the SIMAP resource at the Munich
Three-dimensional structure of CATH domain 1rw8A02Figure 3
Three-dimensional structure of CATH domain 
1rw8A02. 1rw8A02 is member of the Phosphotransferase 
superfamily in CATH (1.10.510.10). 24 positions are 
reported to be pathogenic mutations (PDs, blue).Page 6 of 8
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are resolved into a single set of non-overlapping domains
for each sequence, using the in-house DomainFinder 2.0
protocol. The resulting domain subsequences were then
extracted and dumped into the relevant superfamily
FASTA file.
Gathering the sequences of the CATH domains
For each of the 2097 superfamiles in CATH [22], all CATH
domains were recovered along with the corresponding
amino acid sequences directly from CATH's Oracle data-
base. A total of 86463 CATH domains were found. After-
wards, all CATH domains in the same CATH superfamily
were grouped together in order to build a BLAST database
of the sequences of three-dimensional structures specific
to each of the CATH superfamilies.
Generation of the groups of Gene3D sequences 
represented by the same CATH domain
In order to assign the closest CATH domain to each of the
Gene3D sequences belonging to the same CATH super-
family, we queried each of the sequences in Gene3D
against a database of CATH domains in that superfamily
using BLAST. The best BLAST hit for each of the Gene3D
sequences – provided the identity between the hit and the
query was greater than 20% – was considered the closest
CATH domain and hence the CATH domain was assigned
as the structural representative of this sequence. After per-
forming this classification for the whole set of sequences,
all Gene3D sequences represented by the same CATH
domain were grouped together and all the sequences
within a group considered similar. A total of 2091 unique
groups were generated.
Alignment of the CATH domain groups using MUSCLE
During the previous step of the pipeline, the sequences
contained in each of the groups of Gene3D sequences rep-
resented by the same CATH domain were considered sim-
ilar. However, in order to collapse all the mutations from
the Gene3D sequences onto the representative CATH
domain sequence, the equivalence between pairs of resi-
dues needed to be established. To perform this task, mul-
tiple sequence alignments were constructed using the
alignment package MUSCLE.
Mapping SAAPdb mutations to CATH domain 
representative structures
The alignments generated by MUSCLE during the previ-
ous step of the pipeline were used to transfer the muta-
tions, both pathogenic (PDs) and neutral (SNPs), from
the sequences in Gene3D to the corresponding CATH
structural representatives.
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